1. Home
  2. Analysis
  3. Nasonex
  4. Erythrocin

Nasonex and Erythrocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasonex (mometasone furoate monohydrate) and Erythrocin (erythromycin lactobionate). Common drug interactions include abdominal discomfort among females and eosinophilia among males.

The phase IV clinical study analyzes what interactions people have when they take Nasonex and Erythrocin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Erythrocin?

Erythrocin has active ingredients of erythromycin lactobionate. It is often used in tooth abscess. eHealthMe is studying from 1,200 Erythrocin users. Check the latest studies of Erythrocin.

On Jul, 08, 2026

20 people who take Nasonex and Erythrocin together, and have interactions are studied.

Nasonex and Erythrocin drug interactions.

What are the common drug interactions of Nasonex and Erythrocin, by gender? *:

female:

  1. Abdominal discomfort
  2. Chest discomfort
  3. Decreased appetite
  4. Diarrhoea
  5. Discomfort
  6. Dizziness
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Electrolyte imbalance
  9. Gastroenteritis (inflammation of stomach and intestine)
  10. Headache (pain in head)

male:

  1. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  2. Otitis media (inflammation of the middle ear)
  3. Panic attack
  4. Renal failure (kidney dysfunction)
  5. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  6. Sinusitis (inflammation of sinus)
  7. Asthenia (weakness)
  8. Bipolar disorder (mood disorder)
  9. Chronic kidney disease
  10. Depression

What are the common drug interactions of Nasonex and Erythrocin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

10-19:

  1. Cystic fibrosis (disease of the secretary glands)
  2. Pulmonary function test decreased

20-29:

n/a

30-39:

  1. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  2. Otitis media (inflammation of the middle ear)
  3. Sinusitis (inflammation of sinus)

40-49:

n/a

50-59:

  1. Chest pain
  2. Chronic kidney disease
  3. Joint injury
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Renal failure (kidney dysfunction)
  6. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  7. Thrombosis (formation of a blood clot inside a blood vessel)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Impaired gastric emptying

60+:

  1. Dizziness
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Headache (pain in head)
  4. Hypertension (high blood pressure)
  5. Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
  6. Nausea (feeling of having an urge to vomit)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Vomiting
  10. Anxiety disorder

What are the existing conditions these people have? *

  1. High Blood Pressure: 8 people, 40.00%
  2. Asthma: 8 people, 40.00%
  3. Stress And Anxiety: 7 people, 35.00%
  4. Nausea (feeling of having an urge to vomit): 6 people, 30.00%
  5. Cystic Fibrosis (disease of the secretary glands): 6 people, 30.00%
  6. Infection: 5 people, 25.00%
  7. Pain: 5 people, 25.00%
  8. Depression: 5 people, 25.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 25.00%
  10. Cough: 4 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and Erythrocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nasonex and Erythrocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Erythrocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Erythrocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate and erythromycin lactobionate (the active ingredients of Nasonex and Erythrocin, respectively), and Nasonex and Erythrocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.